| Idiopathic | Iatrogenic | Autoimmune | p value |
---|---|---|---|---|
Demographics | Â | Â | Â | Â |
Number, n (%) | 201 (80.4%) | 19 (7.6%) | 25 (10%) | Â |
Age, years (mean ± SD) | 54.6 ± 13.48 | 53.8 ± 21.93 | 49.3 ± 16.8 | 0.246 |
Age at diagnosis, years (mean ± SD) | 47.8 ± 13.3 | 48.8 ± 22.9 | 43.0 ± 16.3 | 0.276 |
Sex, n (% female) | 192 (95%) | 17 (89%) | 17 (68%) | < 0.001* |
Comorbidities | Â | Â | Â | Â |
Number of comorbidities (mean ± SD) | 1.60 ± 1.35 | 3.37 ± 2.11 | 3.04 ± 2.35 | < 0.001* |
Charlson comorbidity index (mean ± SD) | 0.25 ± 0.86 | 0.79 ± 1.03 | 1.04 ± 0.54 | < 0.001* |
Age-adjusted Charlson comorbidity index, (mean ± SD) | 1.44 ± 1.62 | 2.21 ± 2.10 | 1.96 ± 1.46 | 0.063 |
Gastrointestinal | Â | Â | Â | Â |
 Gastroesophageal reflux disease, n (%) | 65 (32%) | 6 (32%) | 9 (36%) | 0.964 |
 Peptic ulcer disease, n (%) | 0 | 1 (5%) | 1 (4%) | 0.084 |
 Inflammatory bowel diseases, n (%) | 16 (8%) | 3 (16%) | 1 (4%) | 0.346 |
 Liver disease, n (%) | 0 | 2 (11%) | 1 (4%) | 0.003* |
Metabolic/endocrine | Â | Â | Â | Â |
 Hypothyroidism, n (%) | 25 (12%) | 2 (11%) | 2 (8%) | 0.926 |
 Diabetes, n (%) | 15 (7%) | 5 (26%) | 1 (4%) | 0.028* |
 Dyslipidemia, n (%) | 18 (9%) | 2 (11%) | 2 (8%) | 0.909 |
Cardiac | Â | Â | Â | Â |
 Hypertension, n (%) | 42 (21%) | 8 (42%) | 6 (24%) | 0.106 |
 Myocardial infarction, n (%) | 4 (2%) | 1 (5%) | 0 | 0.398 |
 Coronary artery disease, n (%) | 2 (1%) | 1 (5%) | 0 | 0.242 |
 Congestive heart failure, n (%) | 2 (1%) | 1 (5%) | 0 | 0.242 |
 Stroke, n (%) | 2(1%) | 0 | 0 | 1.000 |
Neurologic/psychiatric | Â | Â | Â | Â |
 Fibromyalgia, n (%) | 6 (3%) | 1 (5%) | 3 (12%) | 0.072 |
 Migraines, n (%) | 5 | 5 | 0 | 0.691 |
 Other psychiatric illnesses, n (%) | 10 | 32 | 12 | 0.061 |
Autoimmune/rheumatologic | Â | Â | Â | Â |
 Granulomatosis with polyangiitis, n (%) | 0 | 0 | 14 (56%) | < 0.001* |
 Rheumatoid arthritis, n (%) | 0 | 1 (5%) | 7 (28%) | < 0.001* |
 Other connective tissue disorders, n (%) | 0 | 0 | 3 (12%) | 0.001* |
Respiratory | Â | Â | Â | Â |
 Chronic obstructive pulmonary disease, n (%) | 2 (1%) | 2 (11%) | 0 | 0.043* |
 Asthma, n (%) | 9 (4%) | 5 (26%) | 3 (12%) | 0.002* |
Renal | Â | Â | Â | Â |
 Chronic kidney disease, n (%) | 3 (2%) | 0 | 0 | 1.000 |